ClinicalTrials.Veeva

Menu

Auto-antibodies Prevalence and CD1 Role in Gaucher Disease

H

Hospital Saint Joseph

Status

Completed

Conditions

Gaucher Disease

Treatments

Genetic: genetic analyses

Study type

Observational

Funder types

Other

Identifiers

NCT02650219
ID-RCB 2010-A00315-3

Details and patient eligibility

About

Hypergammaglobulinaemia is frequently observed in type 1 Gaucher disease (GD1), being either polyclonal or monoclonal gammopathies. Polyclonal hypergammaglobulinemia may be related to the presence of autoantibodies. The clinical significance of such antibodies is questioned in Gaucher disease (GD), as some cases of immunologic thrombocytopenia and autoimmune hemolytic anemia have also been reported.

Objectives:

To evaluate the prevalence of autoantibodies and autoimmune diseases in GD1 patients, we conducted a multicenter national study. The investigators investigated whether there was a link between splenectomy, genotype, therapeutic options and the presence of these autoantibodies.They also investigated whether there was a correlation with some clinical manifestations of GD1

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

for GD1 patients

Inclusion Criteria:

  • Adult patients >= 18 years old
  • Gaucher disease type 1, proved by low betaglucosidase, with or without treatment
  • Patients must have read, understood and signed informed consent.

Exclusion Criteria:

  • Under 18 years old
  • Pregnant or breast-feeding
  • Patients under administrative control
  • Prisoners
  • Patients without social rights
  • Emergency hospitalization

Trial design

60 participants in 2 patient groups

gaucher disease type 1
Description:
Inclusion criteria: * Adult patients \>= 18 years old * Gaucher disease type 1, proved by low betaglucosidase, with or without treatment * Patients must have read, understood and signed informed consent. intervention : genetic analyses
Treatment:
Genetic: genetic analyses
Control
Description:
healthy subjects intervention: genetic analyses
Treatment:
Genetic: genetic analyses

Trial contacts and locations

11

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems